MSMatthew Sherwood

Matthew Sherwood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthew Sherwood has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Calvin Johnson

    University of Massachusetts Chan Medical School 3 Division of Hematology-Oncology, Department of Medicine Worcester, Massachusetts

    1 shared publication
  • David Giacalone

    Affiliations Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, Graduate Program in Molecular Microbiology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America

    1 shared publication
  • J. Fraser Glickman

    Affiliation High-Throughput and Spectroscopy Resource Center, The Rockefeller University, New York, New York, United States of America

    1 shared publication
  • Jimmy S. Patel

    Winship Cancer Institute

    1 shared publication
  • Joel S. Freundlich

    Affiliations Department of Pharmacology, Physiology, and Neuroscience, Rutgers University–New Jersey Medical School, Newark, New Jersey, United States of America, Division of Infectious Disease, Department of Medicine and the Ruy V. Lourenco Center for the Study of Emerging and Re-emerging Pathogens, Rutgers University–New Jersey Medical School, Newark, New Jersey, United States of America

    1 shared publication
  • Kyle M. Kremiller

    Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States

    1 shared publication

Latest Publications

  • Open Access

    Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs

    by Richard C. Lavin, Calvin Johnson, Yong-Mo Ahn, Kyle M. Kremiller, Matthew Sherwood, Jimmy S. Patel, Yan Pan, Riccardo Russo, Nathan J. MacGilvary, David Giacalone, et al.

    Sensing and response to environmental cues, such as pH and chloride (Cl−), is critical in enabling Mycobacterium tuberculosis (Mtb) colonization of its host. Utilizing a fluorescent reporter Mtb strain in a chemical screen, we have identified compounds that dysregulate Mtb response to high Cl− levels, with a subset of the hits also inhibiting Mtb growth in host macrophages. Structure–activity relationship studies on the hit compound “C6,” or 2-(4-((2-(ethylthio)pyrimidin-5-yl)methyl)piperazin-1-yl)benzo[d]oxazole, demonstrated a correlation between compound perturbation of Mtb Cl− response and inhibition of bacterial growth in macrophages. C6 accumulated in both bacterial and host cells, and inhibited Mtb growth in cholesterol media, but not in rich media. Subsequent examination of the Cl− response of Mtb revealed an intriguing link with bacterial growth in cholesterol, with increased transcription of several Cl−-responsive genes in the simultaneous presence of cholesterol and high external Cl− concentration, versus transcript levels observed during exposure to high external Cl− concentration alone. Strikingly, oral administration of C6 was able to inhibit Mtb growth in vivo in a C3HeB/FeJ murine infection model. Our work illustrates how Mtb response to environmental cues can intersect with its metabolism and be exploited in antitubercular drug discovery.